U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
KELIXIMAB
INN   WHO-DD  
INN  
Official Name English
IDEC CE-9.1
Preferred Name English
keliximab [INN]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD4 (ANTIGEN)) (HUMAN-MACACA MONOCLONAL CE9.1 G1-CHAIN), DISULFIDE WITH HUMAN-MACACA MONOCLONAL CE9.1 L-CHAIN, DIMER
Common Name English
Keliximab [WHO-DD]
Common Name English
IDEC-CE9.1
Code English
SB-210396
Code English
Code System Code Type Description
FDA UNII
62L6LCF5EU
Created by admin on Wed Apr 02 12:15:27 GMT 2025 , Edited by admin on Wed Apr 02 12:15:27 GMT 2025
PRIMARY
WIKIPEDIA
Keliximab
Created by admin on Wed Apr 02 12:15:27 GMT 2025 , Edited by admin on Wed Apr 02 12:15:27 GMT 2025
PRIMARY
CAS
174722-30-6
Created by admin on Wed Apr 02 12:15:27 GMT 2025 , Edited by admin on Wed Apr 02 12:15:27 GMT 2025
PRIMARY
SMS_ID
100000177671
Created by admin on Wed Apr 02 12:15:27 GMT 2025 , Edited by admin on Wed Apr 02 12:15:27 GMT 2025
PRIMARY
NCI_THESAURUS
C188517
Created by admin on Wed Apr 02 12:15:27 GMT 2025 , Edited by admin on Wed Apr 02 12:15:27 GMT 2025
PRIMARY
INN
7560
Created by admin on Wed Apr 02 12:15:27 GMT 2025 , Edited by admin on Wed Apr 02 12:15:27 GMT 2025
PRIMARY
ChEMBL
CHEMBL2108489
Created by admin on Wed Apr 02 12:15:27 GMT 2025 , Edited by admin on Wed Apr 02 12:15:27 GMT 2025
PRIMARY
ACTIVE MOIETY
KELIXIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966